Regenxbio
RGNX
203 hedge funds and large institutions have $2.16B invested in Regenxbio in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 21 closing their positions.
129% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 21
88% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 49
15% more capital invested
Capital invested by funds: $1.87B → $2.16B (+$289M)
15% more funds holding
Funds holding: 177 → 203 (+26)
0.19% more ownership
Funds ownership: 81.49% → 81.68% (+0.19%)
17% less call options, than puts
Call options by funds: $10.3M | Put options by funds: $12.4M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$68.3M |
| 2 |
BlackRock
New York
|
+$36.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$32.9M |
| 4 |
State Street
Boston,
Massachusetts
|
+$26M |
| 5 |
Renaissance Technologies
New York
|
+$20.6M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$44.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$38.1M |
| 3 |
PA
Perceptive Advisors
New York
|
-$28.6M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$21.5M |
| 5 |
Citigroup
New York
|
-$7.18M |
RGNX Hedge Fund Activity: Q3 2018 in Review
203 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2018, worth a combined $2.16B — up 15% from $1.87B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new RGNX positions and 21 closed out — a net gain of 27 holders — while 92 added to existing stakes and 49 trimmed.
The largest buyer was Vanguard Group, adding an estimated $68.3M. The largest seller was RTW Investments, cutting an estimated $44.7M.
- 203 institutional investors held Regenxbio (RGNX) as of Q3 2018, up from 177 in Q2 2018.
- Funds reported $2.16B of Regenxbio stock for Q3 2018, up 15% quarter-over-quarter.
- 48 funds opened new Regenxbio positions in Q3 2018 and 21 closed out, a net change of +27 holders.
- The largest Regenxbio buyer in Q3 2018 was Vanguard Group, an estimated $68.3M added.
- The largest Regenxbio seller in Q3 2018 was RTW Investments, an estimated $44.7M sold.
Based on aggregated 13F filings for Q3 2018.